The global market for Obesity Treating Neuromodulation System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Neuromodulation has shown some benefit in treatment of obesity and it is less invasive than the gastric banding and gastric bypass, which are surgical treatment option for obesity. Obesity treating neuromodulation system works by manipulation the appetite signal between gut and the brain.

North America region dominates the global obesity treating neuromodulation system market and is expected to continue to dominate the market over the forecast period. High adoption of neuromodulation system and increased regulatory approval of these devices in the region is expected to be factor for the growth of obesity treating neuromodulation system market. Europe is the second biggest market for the obesity treating neuromodulation system. Increasing prevalence of obesity and presence of market players is also driving the market of obesity treating neuromodulation system market in North America and Europe.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Obesity Treating Neuromodulation System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Obesity Treating Neuromodulation System.

The Obesity Treating Neuromodulation System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Obesity Treating Neuromodulation System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Obesity Treating Neuromodulation System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Obesity Treating Neuromodulation System Market Report

Report Metric	Details
Report Name	Obesity Treating Neuromodulation System Market
Segment by Type	Vagus Nerve Stimulator Splanchnic Nerve Stimulator Deep Brain Stimulator Spinal Cord Stimulator Autonomous Nerve Stimulator Others
Segment by Application	Hospitals Clinics Ambulatory Surgical Centers
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Medtronic, Cyberonics, Abbott, BioControl Medical, Leptos Medical, ReShape Lifesciences, Nevro, Nuvectra
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Obesity Treating Neuromodulation System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Obesity Treating Neuromodulation System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Obesity Treating Neuromodulation System Market report?

Ans: The main players in the Obesity Treating Neuromodulation System Market are Medtronic, Cyberonics, Abbott, BioControl Medical, Leptos Medical, ReShape Lifesciences, Nevro, Nuvectra

What are the Application segmentation covered in the Obesity Treating Neuromodulation System Market report?

Ans: The Applications covered in the Obesity Treating Neuromodulation System Market report are Hospitals, Clinics, Ambulatory Surgical Centers

What are the Type segmentation covered in the Obesity Treating Neuromodulation System Market report?

Ans: The Types covered in the Obesity Treating Neuromodulation System Market report are Vagus Nerve Stimulator, Splanchnic Nerve Stimulator, Deep Brain Stimulator, Spinal Cord Stimulator, Autonomous Nerve Stimulator, Others

1 Obesity Treating Neuromodulation System Market Overview

1.1 Product Definition

1.2 Obesity Treating Neuromodulation System by Type

1.2.1 Global Obesity Treating Neuromodulation System Market Value Comparison by Type (2024 VS 2031)

1.2.2 Vagus Nerve Stimulator

1.2.3 Splanchnic Nerve Stimulator

1.2.4 Deep Brain Stimulator

1.2.5 Spinal Cord Stimulator

1.2.6 Autonomous Nerve Stimulator

1.2.7 Others

1.3 Obesity Treating Neuromodulation System by Application

1.3.1 Global Obesity Treating Neuromodulation System Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Ambulatory Surgical Centers

1.4 Global Obesity Treating Neuromodulation System Market Size Estimates and Forecasts

1.4.1 Global Obesity Treating Neuromodulation System Revenue 2020-2031

1.4.2 Global Obesity Treating Neuromodulation System Sales 2020-2031

1.4.3 Global Obesity Treating Neuromodulation System Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Obesity Treating Neuromodulation System Market Competition by Manufacturers

2.1 Global Obesity Treating Neuromodulation System Sales Market Share by Manufacturers (2020-2025)

2.2 Global Obesity Treating Neuromodulation System Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Obesity Treating Neuromodulation System Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Obesity Treating Neuromodulation System, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Obesity Treating Neuromodulation System, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Obesity Treating Neuromodulation System, Product Type & Application

2.7 Global Key Manufacturers of Obesity Treating Neuromodulation System, Date of Enter into This Industry

2.8 Global Obesity Treating Neuromodulation System Market Competitive Situation and Trends

2.8.1 Global Obesity Treating Neuromodulation System Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Obesity Treating Neuromodulation System Players Market Share by Revenue

2.8.3 Global Obesity Treating Neuromodulation System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Obesity Treating Neuromodulation System Market Scenario by Region

3.1 Global Obesity Treating Neuromodulation System Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Obesity Treating Neuromodulation System Sales by Region: 2020-2031

3.2.1 Global Obesity Treating Neuromodulation System Sales by Region: 2020-2025

3.2.2 Global Obesity Treating Neuromodulation System Sales by Region: 2026-2031

3.3 Global Obesity Treating Neuromodulation System Revenue by Region: 2020-2031

3.3.1 Global Obesity Treating Neuromodulation System Revenue by Region: 2020-2025

3.3.2 Global Obesity Treating Neuromodulation System Revenue by Region: 2026-2031

3.4 North America Obesity Treating Neuromodulation System Market Facts & Figures by Country

3.4.1 North America Obesity Treating Neuromodulation System Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Obesity Treating Neuromodulation System Sales by Country (2020-2031)

3.4.3 North America Obesity Treating Neuromodulation System Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Obesity Treating Neuromodulation System Market Facts & Figures by Country

3.5.1 Europe Obesity Treating Neuromodulation System Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Obesity Treating Neuromodulation System Sales by Country (2020-2031)

3.5.3 Europe Obesity Treating Neuromodulation System Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Obesity Treating Neuromodulation System Market Facts & Figures by Region

3.6.1 Asia Pacific Obesity Treating Neuromodulation System Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Obesity Treating Neuromodulation System Sales by Region (2020-2031)

3.6.3 Asia Pacific Obesity Treating Neuromodulation System Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Obesity Treating Neuromodulation System Market Facts & Figures by Country

3.7.1 Latin America Obesity Treating Neuromodulation System Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Obesity Treating Neuromodulation System Sales by Country (2020-2031)

3.7.3 Latin America Obesity Treating Neuromodulation System Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Obesity Treating Neuromodulation System Market Facts & Figures by Country

3.8.1 Middle East and Africa Obesity Treating Neuromodulation System Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Obesity Treating Neuromodulation System Sales by Country (2020-2031)

3.8.3 Middle East and Africa Obesity Treating Neuromodulation System Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Obesity Treating Neuromodulation System Sales by Type (2020-2031)

4.1.1 Global Obesity Treating Neuromodulation System Sales by Type (2020-2025)

4.1.2 Global Obesity Treating Neuromodulation System Sales by Type (2026-2031)

4.1.3 Global Obesity Treating Neuromodulation System Sales Market Share by Type (2020-2031)

4.2 Global Obesity Treating Neuromodulation System Revenue by Type (2020-2031)

4.2.1 Global Obesity Treating Neuromodulation System Revenue by Type (2020-2025)

4.2.2 Global Obesity Treating Neuromodulation System Revenue by Type (2026-2031)

4.2.3 Global Obesity Treating Neuromodulation System Revenue Market Share by Type (2020-2031)

4.3 Global Obesity Treating Neuromodulation System Price by Type (2020-2031)

5 Segment by Application

5.1 Global Obesity Treating Neuromodulation System Sales by Application (2020-2031)

5.1.1 Global Obesity Treating Neuromodulation System Sales by Application (2020-2025)

5.1.2 Global Obesity Treating Neuromodulation System Sales by Application (2026-2031)

5.1.3 Global Obesity Treating Neuromodulation System Sales Market Share by Application (2020-2031)

5.2 Global Obesity Treating Neuromodulation System Revenue by Application (2020-2031)

5.2.1 Global Obesity Treating Neuromodulation System Revenue by Application (2020-2025)

5.2.2 Global Obesity Treating Neuromodulation System Revenue by Application (2026-2031)

5.2.3 Global Obesity Treating Neuromodulation System Revenue Market Share by Application (2020-2031)

5.3 Global Obesity Treating Neuromodulation System Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Medtronic

6.1.1 Medtronic Company Information

6.1.2 Medtronic Description and Business Overview

6.1.3 Medtronic Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Medtronic Obesity Treating Neuromodulation System Product Portfolio

6.1.5 Medtronic Recent Developments/Updates

6.2 Cyberonics

6.2.1 Cyberonics Company Information

6.2.2 Cyberonics Description and Business Overview

6.2.3 Cyberonics Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Cyberonics Obesity Treating Neuromodulation System Product Portfolio

6.2.5 Cyberonics Recent Developments/Updates

6.3 Abbott

6.3.1 Abbott Company Information

6.3.2 Abbott Description and Business Overview

6.3.3 Abbott Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Abbott Obesity Treating Neuromodulation System Product Portfolio

6.3.5 Abbott Recent Developments/Updates

6.4 BioControl Medical

6.4.1 BioControl Medical Company Information

6.4.2 BioControl Medical Description and Business Overview

6.4.3 BioControl Medical Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2020-2025)

6.4.4 BioControl Medical Obesity Treating Neuromodulation System Product Portfolio

6.4.5 BioControl Medical Recent Developments/Updates

6.5 Leptos Medical

6.5.1 Leptos Medical Company Information

6.5.2 Leptos Medical Description and Business Overview

6.5.3 Leptos Medical Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Leptos Medical Obesity Treating Neuromodulation System Product Portfolio

6.5.5 Leptos Medical Recent Developments/Updates

6.6 ReShape Lifesciences

6.6.1 ReShape Lifesciences Company Information

6.6.2 ReShape Lifesciences Description and Business Overview

6.6.3 ReShape Lifesciences Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2020-2025)

6.6.4 ReShape Lifesciences Obesity Treating Neuromodulation System Product Portfolio

6.6.5 ReShape Lifesciences Recent Developments/Updates

6.7 Nevro

6.7.1 Nevro Company Information

6.7.2 Nevro Description and Business Overview

6.7.3 Nevro Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Nevro Obesity Treating Neuromodulation System Product Portfolio

6.7.5 Nevro Recent Developments/Updates

6.8 Nuvectra

6.8.1 Nuvectra Company Information

6.8.2 Nuvectra Description and Business Overview

6.8.3 Nuvectra Obesity Treating Neuromodulation System Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Nuvectra Obesity Treating Neuromodulation System Product Portfolio

6.8.5 Nuvectra Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Obesity Treating Neuromodulation System Industry Chain Analysis

7.2 Obesity Treating Neuromodulation System Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Obesity Treating Neuromodulation System Production Mode & Process Analysis

7.4 Obesity Treating Neuromodulation System Sales and Marketing

7.4.1 Obesity Treating Neuromodulation System Sales Channels

7.4.2 Obesity Treating Neuromodulation System Distributors

7.5 Obesity Treating Neuromodulation System Customer Analysis

8 Obesity Treating Neuromodulation System Market Dynamics

8.1 Obesity Treating Neuromodulation System Industry Trends

8.2 Obesity Treating Neuromodulation System Market Drivers

8.3 Obesity Treating Neuromodulation System Market Challenges

8.4 Obesity Treating Neuromodulation System Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Obesity Treating Neuromodulation System Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Obesity Treating Neuromodulation System Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Obesity Treating Neuromodulation System Market Competitive Situation by Manufacturers in 2024

Table 4. Global Obesity Treating Neuromodulation System Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Obesity Treating Neuromodulation System Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Obesity Treating Neuromodulation System Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Obesity Treating Neuromodulation System Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Obesity Treating Neuromodulation System Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Obesity Treating Neuromodulation System, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Obesity Treating Neuromodulation System, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Obesity Treating Neuromodulation System, Product Type & Application

Table 12. Global Key Manufacturers of Obesity Treating Neuromodulation System, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Obesity Treating Neuromodulation System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Obesity Treating Neuromodulation System as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Obesity Treating Neuromodulation System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Obesity Treating Neuromodulation System Sales by Region (2020-2025) & (K Units)

Table 18. Global Obesity Treating Neuromodulation System Sales Market Share by Region (2020-2025)

Table 19. Global Obesity Treating Neuromodulation System Sales by Region (2026-2031) & (K Units)

Table 20. Global Obesity Treating Neuromodulation System Sales Market Share by Region (2026-2031)

Table 21. Global Obesity Treating Neuromodulation System Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Obesity Treating Neuromodulation System Revenue Market Share by Region (2020-2025)

Table 23. Global Obesity Treating Neuromodulation System Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Obesity Treating Neuromodulation System Revenue Market Share by Region (2026-2031)

Table 25. North America Obesity Treating Neuromodulation System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Obesity Treating Neuromodulation System Sales by Country (2020-2025) & (K Units)

Table 27. North America Obesity Treating Neuromodulation System Sales by Country (2026-2031) & (K Units)

Table 28. North America Obesity Treating Neuromodulation System Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Obesity Treating Neuromodulation System Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Obesity Treating Neuromodulation System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Obesity Treating Neuromodulation System Sales by Country (2020-2025) & (K Units)

Table 32. Europe Obesity Treating Neuromodulation System Sales by Country (2026-2031) & (K Units)

Table 33. Europe Obesity Treating Neuromodulation System Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Obesity Treating Neuromodulation System Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Obesity Treating Neuromodulation System Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Obesity Treating Neuromodulation System Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Obesity Treating Neuromodulation System Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Obesity Treating Neuromodulation System Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Obesity Treating Neuromodulation System Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Obesity Treating Neuromodulation System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Obesity Treating Neuromodulation System Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Obesity Treating Neuromodulation System Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Obesity Treating Neuromodulation System Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Obesity Treating Neuromodulation System Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Obesity Treating Neuromodulation System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Obesity Treating Neuromodulation System Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Obesity Treating Neuromodulation System Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Obesity Treating Neuromodulation System Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Obesity Treating Neuromodulation System Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Obesity Treating Neuromodulation System Sales (K Units) by Type (2020-2025)

Table 51. Global Obesity Treating Neuromodulation System Sales (K Units) by Type (2026-2031)

Table 52. Global Obesity Treating Neuromodulation System Sales Market Share by Type (2020-2025)

Table 53. Global Obesity Treating Neuromodulation System Sales Market Share by Type (2026-2031)

Table 54. Global Obesity Treating Neuromodulation System Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Obesity Treating Neuromodulation System Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Obesity Treating Neuromodulation System Revenue Market Share by Type (2020-2025)

Table 57. Global Obesity Treating Neuromodulation System Revenue Market Share by Type (2026-2031)

Table 58. Global Obesity Treating Neuromodulation System Price (USD/Unit) by Type (2020-2025)

Table 59. Global Obesity Treating Neuromodulation System Price (USD/Unit) by Type (2026-2031)

Table 60. Global Obesity Treating Neuromodulation System Sales (K Units) by Application (2020-2025)

Table 61. Global Obesity Treating Neuromodulation System Sales (K Units) by Application (2026-2031)

Table 62. Global Obesity Treating Neuromodulation System Sales Market Share by Application (2020-2025)

Table 63. Global Obesity Treating Neuromodulation System Sales Market Share by Application (2026-2031)

Table 64. Global Obesity Treating Neuromodulation System Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Obesity Treating Neuromodulation System Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Obesity Treating Neuromodulation System Revenue Market Share by Application (2020-2025)

Table 67. Global Obesity Treating Neuromodulation System Revenue Market Share by Application (2026-2031)

Table 68. Global Obesity Treating Neuromodulation System Price (USD/Unit) by Application (2020-2025)

Table 69. Global Obesity Treating Neuromodulation System Price (USD/Unit) by Application (2026-2031)

Table 70. Medtronic Company Information

Table 71. Medtronic Description and Business Overview

Table 72. Medtronic Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Medtronic Obesity Treating Neuromodulation System Product

Table 74. Medtronic Recent Developments/Updates

Table 75. Cyberonics Company Information

Table 76. Cyberonics Description and Business Overview

Table 77. Cyberonics Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Cyberonics Obesity Treating Neuromodulation System Product

Table 79. Cyberonics Recent Developments/Updates

Table 80. Abbott Company Information

Table 81. Abbott Description and Business Overview

Table 82. Abbott Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Abbott Obesity Treating Neuromodulation System Product

Table 84. Abbott Recent Developments/Updates

Table 85. BioControl Medical Company Information

Table 86. BioControl Medical Description and Business Overview

Table 87. BioControl Medical Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. BioControl Medical Obesity Treating Neuromodulation System Product

Table 89. BioControl Medical Recent Developments/Updates

Table 90. Leptos Medical Company Information

Table 91. Leptos Medical Description and Business Overview

Table 92. Leptos Medical Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Leptos Medical Obesity Treating Neuromodulation System Product

Table 94. Leptos Medical Recent Developments/Updates

Table 95. ReShape Lifesciences Company Information

Table 96. ReShape Lifesciences Description and Business Overview

Table 97. ReShape Lifesciences Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. ReShape Lifesciences Obesity Treating Neuromodulation System Product

Table 99. ReShape Lifesciences Recent Developments/Updates

Table 100. Nevro Company Information

Table 101. Nevro Description and Business Overview

Table 102. Nevro Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Nevro Obesity Treating Neuromodulation System Product

Table 104. Nevro Recent Developments/Updates

Table 105. Nuvectra Company Information

Table 106. Nuvectra Description and Business Overview

Table 107. Nuvectra Obesity Treating Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Nuvectra Obesity Treating Neuromodulation System Product

Table 109. Nuvectra Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Obesity Treating Neuromodulation System Distributors List

Table 113. Obesity Treating Neuromodulation System Customers List

Table 114. Obesity Treating Neuromodulation System Market Trends

Table 115. Obesity Treating Neuromodulation System Market Drivers

Table 116. Obesity Treating Neuromodulation System Market Challenges

Table 117. Obesity Treating Neuromodulation System Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Obesity Treating Neuromodulation System

Figure 2. Global Obesity Treating Neuromodulation System Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Obesity Treating Neuromodulation System Market Share by Type: 2024 & 2031

Figure 4. Vagus Nerve Stimulator Product Picture

Figure 5. Splanchnic Nerve Stimulator Product Picture

Figure 6. Deep Brain Stimulator Product Picture

Figure 7. Spinal Cord Stimulator Product Picture

Figure 8. Autonomous Nerve Stimulator Product Picture

Figure 9. Others Product Picture

Figure 10. Global Obesity Treating Neuromodulation System Market Value by Application (2020-2031) & (US$ Million)

Figure 11. Global Obesity Treating Neuromodulation System Market Share by Application: 2024 & 2031

Figure 12. Hospitals

Figure 13. Clinics

Figure 14. Ambulatory Surgical Centers

Figure 15. Global Obesity Treating Neuromodulation System Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Obesity Treating Neuromodulation System Market Size (2020-2031) & (US$ Million)

Figure 17. Global Obesity Treating Neuromodulation System Sales (2020-2031) & (K Units)

Figure 18. Global Obesity Treating Neuromodulation System Average Price (USD/Unit) & (2020-2031)

Figure 19. Obesity Treating Neuromodulation System Report Years Considered

Figure 20. Obesity Treating Neuromodulation System Sales Share by Manufacturers in 2024

Figure 21. Global Obesity Treating Neuromodulation System Revenue Share by Manufacturers in 2024

Figure 22. Global 5 and 10 Largest Obesity Treating Neuromodulation System Players: Market Share by Revenue in Obesity Treating Neuromodulation System in 2024

Figure 23. Obesity Treating Neuromodulation System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 24. Global Obesity Treating Neuromodulation System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 25. North America Obesity Treating Neuromodulation System Sales Market Share by Country (2020-2031)

Figure 26. North America Obesity Treating Neuromodulation System Revenue Market Share by Country (2020-2031)

Figure 27. U.S. Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Canada Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Europe Obesity Treating Neuromodulation System Sales Market Share by Country (2020-2031)

Figure 30. Europe Obesity Treating Neuromodulation System Revenue Market Share by Country (2020-2031)

Figure 31. Germany Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. France Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. U.K. Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Italy Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Russia Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Asia Pacific Obesity Treating Neuromodulation System Sales Market Share by Region (2020-2031)

Figure 37. Asia Pacific Obesity Treating Neuromodulation System Revenue Market Share by Region (2020-2031)

Figure 38. China Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Japan Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. South Korea Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. India Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Australia Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Taiwan Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Indonesia Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Thailand Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Malaysia Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Philippines Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Latin America Obesity Treating Neuromodulation System Sales Market Share by Country (2020-2031)

Figure 49. Latin America Obesity Treating Neuromodulation System Revenue Market Share by Country (2020-2031)

Figure 50. Mexico Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Brazil Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Argentina Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Middle East and Africa Obesity Treating Neuromodulation System Sales Market Share by Country (2020-2031)

Figure 54. Middle East and Africa Obesity Treating Neuromodulation System Revenue Market Share by Country (2020-2031)

Figure 55. Turkey Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Saudi Arabia Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. UAE Obesity Treating Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Global Sales Market Share of Obesity Treating Neuromodulation System by Type (2020-2031)

Figure 59. Global Revenue Market Share of Obesity Treating Neuromodulation System by Type (2020-2031)

Figure 60. Global Obesity Treating Neuromodulation System Price (USD/Unit) by Type (2020-2031)

Figure 61. Global Sales Market Share of Obesity Treating Neuromodulation System by Application (2020-2031)

Figure 62. Global Revenue Market Share of Obesity Treating Neuromodulation System by Application (2020-2031)

Figure 63. Global Obesity Treating Neuromodulation System Price (USD/Unit) by Application (2020-2031)

Figure 64. Obesity Treating Neuromodulation System Value Chain

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Implantable Neuromodulation Device Market Research Report 2025

Global Non invasive Neuromodulation Device Market Research Report 2024

Global Implantable Neurostimulation System Market Research Report 2024

Non Invasive Neuromodulatory Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Obesity Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Obesity Treatment Surgery Devices Market Insights Forecast to 2030

Global Sacral Neuromodulation System Market Insights Forecast to 2030

Global Minimally Invasive Surgery for Obesity Management Market Research Report 2024

Internal Neuromodulation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Implantable Neurostimulators Market Research Report 2024

Global Ocular Neuromodulation Device Market Research Report 2025

Implantable Neurostimulation Devices Market

Global Home Neuromodulation Device Market Research Report 2024

Global Neuromodulation and Neurostimulation Pain Management Devices Market Research Report 2024

Global Adaptive Neuromodulation Therapy Devices Market Research Report 2024

Internal Neuromodulation Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Neurostimulation and Neuromodulation Device Market Research Report 2024

Global Obesity Surgery Devices Market Insights Forecast to 2030

Global Tibial Neuromodulation Devices Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0I20198

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33W11115

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32E19705

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions